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The major efficacy trials on diabetes prevention have used resource-intensive approaches
to identify high-risk individuals and deliver lifestyle interventions. Such strategies are not fea-
sible for wider implementation in low- and middle-income countries (LMICs). We aimed to
evaluate the effectiveness of a peer-support lifestyle intervention in preventing type 2 diabe-
tes among high-risk individuals identified on the basis of a simple diabetes risk score.
Methods and findings
The Kerala Diabetes Prevention Program was a cluster-randomized controlled trial con-
ducted in 60 polling areas (clusters) of Neyyattinkara taluk (subdistrict) in Trivandrum dis-
trict, Kerala state, India. Participants (age 30–60 years) were those with an Indian Diabetes
Risk Score (IDRS)60 and were free of diabetes on an oral glucose tolerance test (OGTT).
A total of 1,007 participants (47.2% female) were enrolled (507 in the control group and 500
in the intervention group). Participants from intervention clusters participated in a 12-month







Citation: Thankappan KR, Sathish T, Tapp RJ,
Shaw JE, Lotfaliany M, Wolfe R, et al. (2018) A
peer-support lifestyle intervention for preventing
type 2 diabetes in India: A cluster-randomized
controlled trial of the Kerala Diabetes Prevention
Program. PLoS Med 15(6): e1002575. https://doi.
org/10.1371/journal.pmed.1002575
Academic Editor: Ed Gregg, Centers for Disease
Control and Prevention, UNITED STATES
Received: December 6, 2017
Accepted: April 27, 2018
Published: June 6, 2018
Copyright: © 2018 Thankappan et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All data files are
available from the figshare database, https://doi.
org/10.6084/m9.figshare.5661610.
Funding: The research was supported by funding
from the National Health and Medical Research
Council (1005324), https://www.nhmrc.gov.au/,
and the Fogarty International Centre
(D43TW008332), https://www.fic.nih.gov/. The
funders had no role in study design, data collection
community-based peer-support program comprising 15 group sessions (12 of which were
led by trained lay peer leaders) and a range of community activities to support lifestyle
change. Participants from control clusters received an education booklet with lifestyle
change advice. The primary outcome was the incidence of diabetes at 24 months, diag-
nosed by an annual OGTT. Secondary outcomes were behavioral, clinical, and biochemical
characteristics and health-related quality of life (HRQoL). A total of 964 (95.7%) participants
were followed up at 24 months. Baseline characteristics of clusters and participants were
similar between the study groups. After a median follow-up of 24 months, diabetes devel-
oped in 17.1% (79/463) of control participants and 14.9% (68/456) of intervention partici-
pants (relative risk [RR] 0.88, 95% CI 0.66–1.16, p = 0.36). At 24 months, compared with
the control group, intervention participants had a greater reduction in IDRS score (mean
difference: −1.50 points, p = 0.022) and alcohol use (RR 0.77, p = 0.018) and a greater
increase in fruit and vegetable intake (5 servings/day) (RR 1.83, p = 0.008) and physical
functioning score of the HRQoL scale (mean difference: 3.9 score, p = 0.016). The cost of
delivering the peer-support intervention was US$22.5 per participant. There were no
adverse events related to the intervention. We did not adjust for multiple comparisons,
which may have increased the overall type I error rate.
Conclusions
A low-cost community-based peer-support lifestyle intervention resulted in a nonsignificant
reduction in diabetes incidence in this high-risk population at 24 months. However, there
were significant improvements in some cardiovascular risk factors and physical functioning
score of the HRQoL scale.
Trial registration
Australia and New Zealand Clinical Trials Registry ACTRN12611000262909.
Author summary
Why was this study done?
• In low- and middle-income countries (LMICs), there is an urgent need to develop low-
cost strategies for identifying high-risk individuals and delivering lifestyle interventions
to prevent diabetes.
What did the researchers do and find?
• We conducted a cluster-randomized controlled trial in a community-setting in India to
test whether a peer-support lifestyle intervention could reduce diabetes risk at 24
months.
• We identified high-risk individuals on the basis of a simple diabetes risk score.
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• There was a nonsignificant reduction in diabetes risk in this high-risk population at 24
months. However, there were significant improvements in some risk factors for cardio-
vascular disease and a measure of quality of life.
• The intervention cost was low at US$22.5 per participant over 12 months.
What do these findings mean?
• Risk scores for better identifying people at highest risk for diabetes are needed, particu-
larly in resource-constrained settings.
• It is important to identify ways to improve program adherence and engagement, possi-
bly by using more flexible modes of program delivery, e.g., at worksites and by text
messaging.
Introduction
Type 2 diabetes is a major public health problem worldwide [1]. Globally, an estimated 425
million people have diabetes, and the majority of those (79%) are living in low- and middle-
income countries (LMICs) such as India [1]. A large proportion of people with diabetes are
undiagnosed, and many present with complications at the time of diagnosis [1]. Diabetes
imposes a large economic burden on individuals, their families, and national health systems
[1]. Therefore, there is an urgent need to develop and implement effective and cost-effective
measures to prevent diabetes.
The major efficacy trials have shown that lifestyle interventions targeting physical activity,
dietary changes, and weight loss are effective [2–5] and cost-effective [6,7] in preventing type 2
diabetes among people with impaired glucose tolerance (IGT). However, while this is encour-
aging, the real challenge is to deliver such interventions under ‘real-world’ conditions [8]. The
efficacy trials required the expensive oral glucose tolerance test (OGTT) to identify high-risk
individuals and involved specialized multidisciplinary teams (e.g., physicians, nurses, dieti-
cians, exercise physiologists) to deliver interventions. These are important factors limiting the
translation of findings from the efficacy trials to real-world settings, particularly in LMICs,
thereby requiring alternative strategies for identifying high-risk individuals and delivering
interventions [9].
Mass screening with an OGTT to identify high-risk individuals is highly challenging in
LMICs because of the cost and the limited availability of trained clinical staff and accredited
laboratories [10]. Diabetes risk scores are low-cost, noninvasive, and easy-to-administer
screening tools, which could reduce the number of OGTTs when used in a stepwise screening
approach [11]. International guidelines and expert groups recommend using diabetes risk
scores as the first screening step to identify people who may be at high risk, with blood tests
undertaken to confirm high-risk status (i.e., prediabetes). These high-risk individuals can then
be referred to a lifestyle intervention program [12,13]. However, even these approaches require
blood testing on up to 50% of adults, posing difficulties in low-resource settings.
Lifestyle interventions evaluated in the major efficacy trials have involved resource-inten-
sive, individualized counselling delivered on a one-to-one basis or in groups by highly trained
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health professionals [2–5]. In the Chinese Da Qing IGT and Diabetes Study [3], physicians
delivered one individual counselling session and group counselling sessions every week for
one month, followed by monthly for three months and every three months for the next 5.8
years. In the United States Diabetes Prevention Program (US DPP) [2], participants in the life-
style intervention group received 16 individual counselling sessions from case managers
within the first 24 weeks following randomization, and then, face-to-face contacts (individual
or group) were made every two months for another 2.5 years. Over three years, the interven-
tion costs were US$2,780 per participant [14]. In the Finnish Diabetes Prevention Study [5],
participants received one-to-one individualized counselling sessions from nutritionists. Seven
sessions were delivered in the first year and one session every three months thereafter until the
end of the study at six years. Exercise physiologists guided participants to increase their physi-
cal activity through individualized resistance training sessions. In the Indian Diabetes Preven-
tion Programme (IDPP) [4], although the intervention was less labor- and resource-intensive
(US$225 per participant over three years) [6] than other efficacy trials, it was delivered on a
one-to-one basis by physicians, dieticians, and social workers. These intervention strategies
are not feasible for wider implementation in real-world settings in LMICs, where the burden
of diabetes is substantial [1] and where the availability of highly trained health professionals
for program delivery is very limited [15]. Peer support is an alternative strategy to encourage
people to make and sustain healthy lifestyle changes [16]. Peer support refers to the provision
of practical, social, and emotional ongoing support from nonprofessionals for complex health
behaviors [17]. A recent systematic review has shown that peer support is effective in bringing
behavior change in prevention and management of various health conditions, including HIV/
AIDS, maternal and child health, and mental health, as well as diabetes, cardiovascular disease,
and other chronic conditions [17]. Peer-support interventions are low-cost, culturally appro-
priate, and potentially scalable [17].
The Kerala Diabetes Prevention Program (K-DPP) was a cluster randomized controlled trial
(RCT) of a peer-support lifestyle intervention implemented in a community setting in India
[18]. In this paper, we aimed to examine whether the intervention could reduce diabetes inci-
dence at 24 months among high-risk individuals identified on the basis of a diabetes risk score.
Methods
Ethics statement
The study was approved by the Health Ministry Screening Committee of the Government of
India; ethics committees of the Sree Chitra Tirunal Institute for Medical Sciences and Tech-
nology (SCT/IEC-333/May 2011), Trivandrum, India; Monash University (CF11/0457-
2011000194); and The University of Melbourne (1441736) in Australia. Written informed con-
sent was obtained from all study participants.
Study design
This study is reported in accordance with the Consolidated Standards of Reporting Trials
guidelines for cluster RCTs (S1 Checklist) [19]. The details of the K-DPP study design have
been described in detail elsewhere [18], and the protocol is available at https://link.springer.
com/article/10.1186/1471-2458-13-1035. Briefly, K-DPP was a cluster RCT conducted in 60
polling areas (clusters) of Neyyattinkara taluk (subdistrict) in Trivandrum district, Kerala
state. Polling areas are well-defined and identifiable locations demarcated with landmarks
such as hills, rivers, roads, streets, etc. by the Election Commission of India [20]. A cluster
design was chosen for the study, as the risk of contamination would otherwise be high among
individuals from the same community.
K-DPP and type 2 diabetes
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Randomization and masking
At the time of study enrolment, Neyyattinkara taluk had 603 polling areas across four legisla-
tive assembly constituencies (LACs). Although there were maps available to locate polling
areas in each of the four LACs, there was no single map connecting the four LACs, which
could show the contiguous polling areas across the borders of LACs. To reduce the risk of
selecting contiguous polling areas, we removed 244 polling areas that were located along the
borders of the four LACs and selected at random 60 of the remaining 359 polling areas. The 60
polling areas were then randomly assigned in a 1:1 ratio to the control group (received an edu-
cation booklet on general lifestyle advice) or the intervention group (peer-support lifestyle
intervention) by an independent statistician using a computer-generated randomization
sequence. After randomization, in both the intervention and control groups, there were two
contiguous polling areas. Therefore, one polling area from each pair was replaced with a
nearby polling area, which were at least two kilometers apart. Participants were masked to
group assignment until the completion of the baseline assessment. Field staff members admin-
istering questionnaires (no group-specific questions were included in the questionnaires) and
undertaking measurements at baseline and follow-ups, along with laboratory technicians and
investigators, were masked. Field staff members administering the process evaluation ques-
tionnaire to intervention participants were not masked.
Participants
From the electoral roll of each of the 60 polling areas, 80 individuals (age 30 to 60 years) were
selected randomly and were approached through home visits. Eligibility criteria included no
history of diabetes or other chronic illness that might affect their participation in the trial,
being literate in the local language (Malayalam), not being pregnant, and not taking medica-
tions known to affect glucose tolerance (glucocorticoids, antiretroviral drugs and antipsychot-
ics). Those satisfying the eligibility criteria were screened using the Indian Diabetes Risk Score
(IDRS), which comprises four simple parameters: age, family history of diabetes, physical
activity (regular exercise or strenuous work), and waist circumference [21]. At the time of
study enrolment, the IDRS was the only risk score from India that had been previously evalu-
ated in a cohort study, with a score of60 being a strong predictor of incident diabetes in
Asian Indians [22]. Therefore, we chose the IDRS to screen and recruit our trial participants.
Those with an IDRS score60 were invited to attend a community-based clinic to undergo a
75-gm OGTT. Clinics were conducted in local neighborhoods in community buildings (e.g.,
schools, library halls, church halls). The OGTT was performed according to the World Health
Organization (WHO) guidelines [23]. A venous blood sample was taken after an overnight fast
for at least eight hours, and a second blood sample was collected two hours after oral ingestion
of 75-g glucose dissolved in 250–300 ml of water. Those with fasting plasma glucose (FPG)
7.0 mmol/l or 2-hr plasma glucose (2-hr PG)11.1 mmol/l or both were diagnosed to have
diabetes based on the American Diabetes Association (ADA) criteria [12]. They were then
referred to a healthcare facility and were excluded from the study. The remaining individuals
were enrolled in the trial irrespective of their baseline glucose tolerance. If the participant had
not fasted for the recommended time, they were asked to attend another clinic in a nearby
neighborhood on a different day.
Interventions
Detailed information on the development and cultural adaptation of the intervention program
have been reported elsewhere [24,25]. Briefly, the main theory underpinning the intervention
program was the Health Action Process Approach model [26] with more emphasis given to
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collectivistic rather than individualistic strategies during the intervention design phase. The
intervention program was adapted from the Finnish Good Ageing in Lahti Region (GOAL)
program [27] and the Australian Greater Green Triangle (GGT) Diabetes Prevention Project
[28] through situational analysis, needs assessment, and cultural translation [24,25]. This adap-
tation process was guided by the Intervention Mapping Approach [29]. The program utilized
the core functions of peer support identified in the US Peers for Progress Program [16] and
incorporated behavior change strategies that were identified from the needs assessment study
[25]. The intervention model and program were tested and further refined following piloting
with two groups in 2012–2013 [18].
The 12-month peer-support program consisted of 15 group sessions: an introductory ses-
sion delivered by the K-DPP team; two education sessions conducted by local experts; and 12
sessions delivered by trained lay peer leaders. An introductory session was planned to intro-
duce the group participants to the program and its mentoring style. The needs assessment
study showed that at least one peer group session per month would be optimal and feasible to
deliver the intervention [25], and thus 12 peer group sessions were planned. The needs assess-
ment study also emphasized the importance of including sessions on diabetes prevention and
management by local experts, as the knowledge on these among people with prediabetes in
Kerala was low [25]. Furthermore, during the pilot phase [18], peer leaders were selected from
within the groups, and their level of diabetes-specific knowledge was also limited. Therefore,
we decided that information would be delivered by experts through two education sessions,
and the peer leaders’ role would be to help participants to translate the information into their
daily lives. To minimize resources, the education sessions were delivered to participants from
two to three neighborhoods within close proximity. Participants were encouraged to bring
family members along to further extend the reach of the education.
Group sessions and community activities. All group sessions were held in the local com-
munity in a convenient neighborhood facility (e.g., schools, community halls). Sessions were
conducted during weekends at a convenient time for participants. In the introductory group
session (lasted for 60–90 minutes), the K-DPP team introduced the program and its benefits to
the participants and their family members. The two education sessions (each lasting for half a
day) were conducted by experts in the field of diabetes, nutrition, and physical activity. These
sessions focused on the etiology of diabetes, risk factors, misconceptions around diabetes, and
the role of lifestyle change in preventing and managing diabetes. The experts also reinforced
the role and importance of peer support in behavior change and encouraged participants to
attend the peer group sessions. During the introductory group session, each group selected
two peer leaders (one male, one female) from among their participants with assistance from
the K-DPP team. Peer leaders were identified on the basis of their willingness to lead the
group, social credibility, and acceptability by the group. Peer groups consisted of 10 to 23 par-
ticipants, with approximately equal numbers of males and females. The first two peer group
sessions were held fortnightly, and the subsequent 10 sessions were held every month thereaf-
ter, with each session lasting 60 to 90 minutes. Each session had specific objectives and struc-
tured content to be covered, which maps onto interventions delivered in the Finnish GOAL
program [27,30] and the Australian GGT project [28] (refer to S1 Table for further details).
Based on a sociobehavioral intervention model for lifestyle change [26], the peer group ses-
sions aimed to achieve the following key lifestyle objectives:
• Increasing physical activity
• Promoting healthy eating habits
• Maintaining appropriate body weight by balancing calorie intake and physical activity
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• Tobacco cessation
• Reducing alcohol consumption
• Ensuring adequate sleep
Lifestyle change strategies for increasing physical activity focused on identifying enjoyable
activities for individuals and groups (e.g., walking groups, yoga sessions) and building those
activities into each participant’s daily routine. Advice on healthy diet included increasing the
intake of fruits and vegetables and reducing the portion size of rice and intake of fried foods
and refined sugars. Participants used goal setting, action planning and self-recording of activi-
ties in their program workbook as key behavioral strategies for increasing physical activity and
healthy eating. Participants received a handbook containing information on peer support, its
benefits, and its role in assisting with sustainable lifestyle changes related to reducing diabetes
risk. Body weight of participants was measured during the peer group sessions. Peer leaders
also had regular contact with their group participants between the formal group sessions in
order to reinforce the program objectives, update on the content of missed sessions, and
encourage goal attainment and attendance at the next peer group session. Group participants
were also encouraged by their peer leaders to participate in community activities such as estab-
lishing kitchen gardens, yoga training, and walking groups to support lifestyle change. These
activities were led by peer leaders with assistance from local resource persons (LRPs) (commu-
nity volunteers). While groups were encouraged to keep meeting at completion of the formal
program at 12 months, there was no structured support provided for this.
Training, quality assurance and support for peer leaders. Peer leaders were provided
two training sessions (each of two days’ duration) by the K-DPP staff members: an interven-
tion manager (registered nurse with a PhD in public health) and an intervention assistant
(medical social worker). These sessions aimed to build peer leaders’ basic knowledge about
diabetes, to emphasize the role of a peer leader, and to provide skills on group facilitation,
communication, goal setting, and promoting community activities. Refer to S1 Text for the
content of these training sessions. Peer leaders were provided with a workbook, which outlined
peer group sessions’ objectives, along with an activity guide and exercises to prepare them for
conducting the sessions. Peer leaders were also given measuring cups and spoons to assist
them in educating the participants about the daily recommended food quantities such as con-
sumption of oil, sugar, salt, rice, and vegetables. Trained LRPs were asked to attend the peer
group sessions as observers and to complete a detailed checklist to ensure program fidelity.
During the program delivery, peer leaders were also supported in the following ways:
• Telephone calls were made by the K-DPP team before and after each session to discuss the
sessions and any challenges faced by the peer leaders.
• Practical support was provided by LRPs to help organize the logistics for local program
delivery.
• Reimbursement of costs for attending training sessions was provided.
Control participants received an education booklet concerning information about diabetes
and its risk factors, as well as standard advice about lifestyle change.
Procedures
Participants were assessed at baseline, 12 months, and 24 months. During each assessment,
field staff members administered standardized and validated questionnaires to collect mea-
sures of sociodemographic characteristics, lifestyle behaviors, medical history, and health-
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related quality of life (HRQoL). Self-reported levels of physical activity were measured using
the Global Physical Activity Questionnaire [31]. Intake of fruits and vegetables were assessed
using a food frequency questionnaire [32]. HRQoL was assessed using the 36-item Short-Form
(SF-36) health survey [33]. The SF-36 is divided into eight scales (physical functioning, role
limitation—physical, role limitation—emotional, bodily pain, general health, mental health,
social functioning, and vitality) and two domains (physical component summary and mental
component summary). Scores for each of the scales and domains range from 0 to 100, with
higher scores indicating better quality of life. The SF-36 data were converted into a six-dimen-
sional health state called the Short Form 6 Dimension (SF-6D), whose score ranges between
0.29 (worse health) and 1.00 (full health). Following the 12-month intervention period, a
process evaluation questionnaire was administered to intervention participants by field staff
members who were different from those administering main questionnaires. During each
assessment, anthropometry (height, weight, fat percent, muscle mass, waist circumference,
and hip circumference) and blood pressure were measured, and blood samples were taken for
the OGTT, HbA1c, and lipids according to standard protocols [34]. Individuals diagnosed
with diabetes on the OGTT at 12-month follow-up were referred to healthcare facilities for
treatment and care. However, they were still followed-up, although an OGTT was not per-
formed at 24 months; instead, FPG alone was measured. Blood samples were centrifuged
within 30 minutes of collection and transported in boxes with dry ice to a nationally accredited
laboratory. Plasma glucose was measured using the hexokinase method on a COBAS 6000 ana-
lyzer, with kits supplied from Roche Diagnostics, Switzerland. HbA1c was measured using the
high-performance liquid chromatography method on a D-10 BIORAD analyzer and lipids by
enzymatic methods on a COBAS 6000 analyzer, using kits supplied by Roche Diagnostics,
Switzerland. Low-density lipoprotein (LDL) cholesterol was estimated using the Friedewald
equation [35] for participants with triglycerides4.52 mmol/l, and for the rest, values
obtained from the direct method were used in the analysis.
Outcomes
The primary outcome was the incidence of diabetes at 24 months, diagnosed by an annual
OGTT, according to the ADA criteria (FPG7.0 mmol/l and/or 2-hr PG11.1 mmol/l) [12].
Participants who were diagnosed with diabetes by a physician and taking antidiabetic medica-
tions (‘clinical diagnosis’) subsequent to entry in the trial were also included in the primary
outcome. Secondary outcomes included weight, waist circumference, waist-to-hip ratio, fat
percent, muscle mass, systolic and diastolic blood pressure, FPG, 2-hr PG, HbA1c, lipid pro-
file, IDRS score,5 servings of fruit and vegetables intake per day, physical activity, tobacco
use, alcohol use, and HRQoL.
Statistical analysis
Assuming an annual incidence of diabetes of 18.3% in the control group [4], an intracluster
correlation coefficient (ICC) of 0.02 for plasma glucose [36], an average of 17 participants per
group, at 5% significance with 80% power, allowing a loss to follow-up of 10%, the numbers of
participants and polling areas per study group required were 510 and 30 respectively, to detect
a relative risk reduction (RRR) of 30% at 24 months [18]. Funding dictated that the primary
outcome be measured at 24 months’ follow-up. Since ICC values for diabetes incidence were
not available from published studies, ICC for plasma glucose from a previous study [36] was
used. However, a positive ICC for diabetes incidence was not observed in the trial. Hence, the
32% inflation of sample size for a design effect was redundant.
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Baseline characteristics of clusters and participants are summarized using mean and stan-
dard deviation (SD) or median and interquartile range (IQR) for continuous variables and fre-
quency and percentage for categorical variables. The analyses observed intention-to-treat, i.e.,
participants and clusters were analyzed according to the group to which they were allocated.
There were a few changes to the analysis plan specified in the study protocol [18]. For the pri-
mary outcome analysis, instead of logistic regression and Cox-proportional hazards regression,
to estimate the relative risk (RR) (and 95% confidence interval [CI] and P value) at 24 months,
we used log binomial models estimated by generalized estimating equations (GEE) with an
exchangeable working correlation structure and robust standard errors to account for cluster-
ing by polling areas. This approach gave improved interpretability of the intervention effect (as
increased cumulative incidence (RR) rather than increased odds) and accorded with the use of
RR in the protocol’s sample size. As diabetes was only observed systematically at 12- and
24-month time points a discrete time proportional hazards model was considered appropriate
in place of the Cox model but this model provides little extra information above and beyond
the log-binomial model for diabetes incidence at 12 and 24 months. We also conducted post
hoc subgroup analyses by baseline glucose tolerance: normal glucose tolerance (NGT), isolated
impaired fasting glucose (IFG), and IGT defined by the ADA criteria [12] and the WHO crite-
ria [23]. To examine the heterogeneity of intervention effect by subgroup, an interaction term
between the intervention assignment and subgroup was included in the GEE models, and its
significance was tested using the Wald test. The subgroup analyses were done because the cur-
rent literature on diabetes prevention programs has been largely limited to people with IGT
[37], yet the target population in the real world is much broader.
For the analysis of continuous secondary outcomes, mixed-effects linear regression models
were used and included outcomes at baseline, 12 months and 24 months, and included all par-
ticipants with outcome data available at one or more of these timepoints. Skewed variables
were log-transformed before analysis. Study group (intervention vs. control), timepoint (fol-
low-up vs. baseline) and a study group-by-timepoint interaction were specified as fixed effects.
Random effects were specified for polling areas, to account for the clustered study design, and
for participants, to account for correlation between the repeated measurements on the same
individual. The P value of the study-group-by-timepoint interaction was used to test the differ-
ence in change between study groups. For categorical secondary outcomes, the log binomial
model was used.
We assessed the sensitivity of the primary outcome analysis to missing outcome data using
multilevel multiple imputation (MMI), accounting for clustering [38]. We performed 10 impu-
tations using GEE to fit log binomial imputation models for missing outcomes and with study
group and the following baseline covariates included as auxiliary variables: age, sex, education,
occupation, monthly household expenditure, current tobacco use, current alcohol use, fruit
and vegetable intake (in servings/day), leisure time physical activity, family history of diabetes,
body mass index, waist-to-hip ratio, fat percent, muscle mass, systolic blood pressure, diastolic
blood pressure, FPG, 2-hr PG, HbA1c, LDL cholesterol, and triglycerides. The log RR (and its
standard error) was computed on each multiply imputed dataset, and the results were com-
bined to obtain the multiple imputation estimate using Rubin’s rule [39]. MMI was performed
using the R Jomo package [40].
The costs associated with delivering the peer-support intervention over 12 months were
estimated across five major categories (training sessions for peer leaders and LRPs, group ses-
sions, resource materials, administrative costs, and community activities). The K-DPP person-
nel (intervention manager and intervention assistant) were interviewed to estimate the
amount of time they spent on various intervention activities. Personnel costs were calculated
based on the actual salary (or remuneration) paid to the intervention manager, intervention
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assistant, local experts, and LRPs. Nonpersonnel costs (travel, food and logistics, rent for ven-
ues, phone calls, designing and printing charges for resource materials, and administrative
costs) were estimated based on the actual expenditure. The cost figures were obtained from the
finance registers. The cost estimates in Indian Rupees (INR) were converted to US dollars
using an exchange rate of INR58.6 = US$1 for the year 2013 [41].
A two-sided P value <0.05 was considered statistically significant for all analyses. Analyses
were performed using Stata version 14.2 (StataCorp LP, College Station, Texas, USA), R 3.4.3,
or Microsoft Excel 2016 (Microsoft corporation, Redmond, Washington, USA).
Results
Participant flow and characteristics
Participants from the 60 polling areas were recruited between January 20, 2013, and October
27, 2013. Fig 1 shows the trial profile. A total of 3,689 individuals were contacted through
home visits, of whom 137 (3.7%) did not satisfy the age criteria and were therefore excluded.
Of the remaining 3,552 individuals, 131 (3.7%) declined participation, and 3421 were assessed
for eligibility, of whom 835 (24.4%) were not eligible. Of 2,586 eligible individuals screened
with the IDRS, 1,529 (59.1%) had a score60, of whom 1,209 (79.1%) attended community-
based clinics and underwent an OGTT. After excluding 202 (16.7%) individuals with diabetes,
1,007 (507 in the control group and 500 in the intervention group) were enrolled in the trial.
Baseline characteristics of clusters and participants were similar between the study groups
(Table 1). Participants’ mean age was 46.0 years, and the majority were male (52.8%), educated
up to secondary school (75.6%), and employed (72.3%). According to the ADA criteria [12],
11.5% had IGT, 57.5% had isolated IFG, and 31.0% had NGT. The corresponding figures for
the WHO criteria [23] were 11.5%, 22.5%, and 66.0%, respectively. The prevalence of several
cardiovascular risk factors was high at baseline, as reported previously [42]. All clusters and
95.7% (964/1007) of participants were followed-up at 24 months (95.1% in the control group;
96.4% in the intervention group).
Process evaluation
Of the 15 total program sessions, participants attended a median of 9 (IQR 3 to 13) sessions;
10.8% attended all 15 sessions, 62.4% attended seven or more sessions, and 89.2% attended at
least one of these sessions. Twenty-nine out of 30 groups delivered all of their 12 peer group ses-
sions, according to the intervention protocol. Nearly two-thirds (61.8%, 309/500) of interven-
tion participants reported that they had regular contact with peer leaders outside the formal
group sessions during the 12-month program, with a mean number of contacts being 11.3 (SD
8.1). More than half (57.2%, 286/500) reported participation in community activities, including
yoga sessions, kitchen gardening, and walking groups. Among those who did not attend formal
program sessions (n = 54), one-third (33.3%) still reported that they had regular contact with
their peer leaders outside the group sessions, and 16.7% also reported participating in commu-
nity activities. Overall, only 27 participants (5.4%) did not have any exposure to the program.
Incidence of diabetes
After a median follow-up of 24 months, overall, diabetes developed in 147 participants (144
were diagnosed on the OGTT and 3 were clinically diagnosed): 17.1% (79/463) of participants
in the control group and 14.9% (68/456) of participants in the intervention group. The RR was
0.88 (95% CI 0.66–1.16), p = 0.36. The RR did not change appreciably after excluding those
with baseline HbA1c6.5% (n = 52) (ADA [12] and International Expert Committee [43]
K-DPP and type 2 diabetes
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Fig 1. Trial profile. IDRS, Indian Diabetes Risk Score; OGTT, oral glucose tolerance test.
https://doi.org/10.1371/journal.pmed.1002575.g001
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Table 1. Baseline characteristics of clusters and participants by study group.
Excluded = 250:
Not able to speak, read and write the local language = 40
Known T2DM = 160
Other chronic illness = 39
Pregnancy = 2
Taking medications known to influence glucose tolerance = 9
Control group Intervention group
Cluster level
No. of polling areas 30 30
Average no. of individuals/polling area 1100 1150
Individual level
No. of participants 507 500
Socio-demographic characteristics
Age (years), mean (SD) 45.7 (7.4) 46.2 (7.6)






























Monthly household expenditure (INR), median (IQR) 6000 (5000 to 10000) 7000 (5000 to 10000)

















Weight (kg), mean (SD) 64.5 (12.1) 62.6 (11.6)
Waist circumference (cm), mean (SD) 88.7 (9.7) 87.9 (9.7)
Waist-to-hip ratio, mean (SD) 0.93 (0.06) 0.93 (0.07)
Fat percent (percent), mean (SD) 30.0 (8.7) 29.7 (8.2)
Muscle mass (kg), mean (SD) 42.4 (8.4) 41.5 (8.3)
Systolic blood pressure (mmHg), mean (SD) 123.4 (17.9) 123.0 (17.6)
Diastolic blood pressure (mmHg), mean (SD) 74.8 (12.1) 75.0 (11.5)
IDRS score, mean ± SD 67.5 (8.4) 66.8 (8.3)
Bio-chemical characteristics
Fasting plasma glucose (mmol/l), mean (SD) 5.8 (0.5) 5.8 (0.5)
2-hr plasma glucose (mmol/l), mean (SD) 6.0 (1.5) 5.9 (1.6)
HbA1c (percent), mean (SD) 5.6 (0.5) 5.6 (0.5)
Total cholesterol (mmol/l), mean (SD) 5.7 (1.1) 5.7 (1.0)
LDL cholesterol (mmol/l), mean (SD) 3.8 (0.9) 3.8 (0.9)
Triglycerides (mmol/l), median (IQR) 1.1 (0.9 to 1.6) 1.2 (0.9 to 1.6)
Behavioral characteristics
5 servings of fruit and vegetables/daya, n (percent) 84 (16.6) 91 (18.2)
Physically active (leisure time)b, n (percent) 102 (20.4) 107 (21.1)
Current tobacco usec, n (percent) 92 (18.2) 102 (20.4)
Current alcohol used, n (percent) 97 (19.1) 114 (22.8)
(Continued)
K-DPP and type 2 diabetes
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002575 June 6, 2018 12 / 23
cutoff value for diabetes) (RR 0.93, 95% CI 0.66–1.31, p = 0.66) and was similar to the results
obtained using MMI (RR 0.86, 95% CI 0.61–1.13), p = 0.29.
The RR in the IGT subgroup (ADA and WHO criteria: 0.66, 95% CI 0.45–0.98, p = 0.038)
was lower than that in the isolated IFG (ADA criteria: 0.95, 95% CI 0.68–1.33, p = 0.77; WHO
criteria: 0.98, 95% CI 0.68–1.42, p = 0.92) or NGT (ADA criteria: 1.23, 95% CI 0.36–4.26;
WHO criteria: 1.15, 95% CI 0.66–2.01, p = 0.63) subgroups. However, there was no evidence
in favor of an interaction between baseline glucose tolerance and study group on diabetes inci-
dence (ADA criteria: p = 0.24; WHO criteria: p = 0.11).
Secondary outcomes
Table 2 shows the changes in clinical and biochemical characteristics by study group at 24
months. The IDRS score reduced in both study groups, but the reduction was greater in the
Table 1. (Continued)
Excluded = 250:
Not able to speak, read and write the local language = 40
Known T2DM = 160
Other chronic illness = 39
Pregnancy = 2
Taking medications known to influence glucose tolerance = 9
Control group Intervention group
Standard drinks of alcohol (per drinking occasion)e, mean (SD) 0.2 (0.4) 0.2 (0.4)
Medical history
Family history of diabetes, n (percent) 260 (51.3) 222 (44.4)
Anti-hypertensive drugs, n (percent) 40 (7.9) 35 (7.0)
Lipid-lowering drugs, n (percent) 12 (2.4) 9 (1.8)
Health-Related Quality of Life variables
Physical functioning, mean (SD) 77.8 (23.4) 75.6 (23.5)
Bodily pain, mean (SD) 70.5 (29.4) 69.9 (28.8)
Role limitation - physical, mean (SD) 83.8 (21.6) 82.2 (22.0)
Role limitation - emotional, mean (SD) 84.4 (21.9) 83.4 (23.0)
Social functioning, mean (SD) 88.1 (20.3) 87.1 (22.3)
Vitality, mean (SD) 73.2 (20.8) 74.0 (20.5)
General health, mean (SD) 64.6 (24.7) 64.9 (23.5)
Mental health, mean (SD) 76.7 (19.8) 79.4 (19.0)
Physical component summary, mean (SD) 49.9 (8.5) 49.1 (8.7)
Mental component summary, mean (SD) 53.2 (9.1) 54.0 (9.1)
SF-6D, mean (SD) 0.78 (0.15) 0.78 (0.15)
Abbreviations: IDRS, Indian Diabetes Risk Score; INR, Indian Rupees; IQR, interquartile range; LDL, low density
lipoprotein; SD, standard deviation; SF-6D, Short Form 6 Dimension. Percentages may not add up to 100% due to
rounding.
a One serving of fruit equals a medium-sized fruit or two small-sized fruits or half a glass of fruit juice or a bowl of
grapes. One serving of vegetables (excludes tubers) equals 80 grams.
b Self-reported history of moderate or vigorous physical activities during leisure time performed in bouts of at least
10 minutes’ duration.
c Smoking or use of smokeless tobacco products (chewing tobacco and snuff) in the past 30 days.
d Drank an alcoholic drink in the past 30 days.
e One standard drink of alcohol refers to 30 ml of spirits, 120 ml of wine, 285 ml of beer, or 285 ml of toddy (palm
wine).
https://doi.org/10.1371/journal.pmed.1002575.t001
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intervention group by 1.50 points (p = 0.022). Table 3 shows the changes in behavioral charac-
teristics by study group at 24 months. Compared with the control participants, intervention par-
ticipants were more likely to consume5 servings of fruit and vegetables per day by 83%
(p = 0.008). Intervention participants were 23% less likely to consume alcohol compared with
the control participants (p = 0.018), and the amount of alcohol consumed was lower among
intervention participants (p = 0.030). Table 4 shows the changes in HRQoL variables by study
group at 24 months. Compared with the control group, the intervention participants had a
greater increase in physical functioning score of the HRQoL scale by 3.9 points (p = 0.016). The
12-month changes in secondary outcomes by study group are given in S2, S3 and S4 Tables.
Intervention costs
Table 5 shows the costs associated with delivering the peer-support intervention over 12
months. The total intervention costs amounted to US$11,225 (US$22.5 per participant). The
group sessions were the largest cost contributor (52.8% of total costs), followed by designing
and printing charges for resource materials (21.7%), administrative costs (13.8%), and training
of peer leaders and LRPs (11.7%). Personnel costs accounted for 26.7% of the total costs. Com-
munity activities incurred no program costs.
Adverse events
We recorded no adverse events related to the intervention.
Discussion
Summary of principal findings
To our knowledge, K-DPP is the first RCT from a LMIC to evaluate the effectiveness of a peer-
support lifestyle intervention delivered mainly by lay people in a community setting. This
Table 2. Changes in clinical and biochemical characteristics at 24 months by study group.
Control group Intervention group
Mean change (SD) Mean change (SD) Difference (95% CI) P value
Weight (kg) 1.24 (2.91) 1.22 (3.27) 0.01 (−0.34 to 0.36) 0.95
Waist circumference (cm) 0.63 (6.97) −0.07 (5.95) −0.67 (−1.56 to 0.22) 0.14
Waist-to-hip ratio −0.011 (0.062) −0.020 (0.078) −0.008 (−0.018 to 0.002) 0.12
Fat percent (percent) 0.54 (3.17) 0.61 (2.77) 0.10 (−0.29 to 0.48) 0.62
Muscle mass (kg) 0.52 (3.43) 0.42 (1.69) −0.10 (−0.39 to 0.20) 0.52
Fasting plasma glucose (mmol/l) 0.230 (0.988) 0.225 (0.811) 0.014 (−0.088 to 0.115) 0.79
Two-hour plasma glucose (mmol/l) 0.47 (2.11) 0.43 (1.97) −0.07 (−0.34 to 0.20) 0.63
HbA1c (percent) 0.056 (0.603) −0.003 (0.430) −0.058 (−0.122 to 0.006) 0.08
Systolic blood pressure (mmHg) 0.28 (13.29) −0.92 (13.44) −1.22 (−2.80 to 0.35) 0.13
Diastolic blood pressure (mmHg) −0.49 (9.74) −1.59 (9.86) −1.12 (−2.29 to 0.05) 0.06
Total cholesterol (mmol/l) −0.11 (0.87) −0.13 (0.80) −0.01 (−0.11 to 0.08) 0.79
LDL cholesterol (mmol/l) −0.09 (0.79) −0.11 (0.73) −0.02 (−0.11 to 0.07) 0.73
Triglycerides (mmol/l)† 1.11 (46.22) 1.06 (44.99) 0.96 (0.91 to 1.00) 0.07
IDRS score −4.36 (9.61) −5.74 (10.86) −1.50 (−2.78 to −0.22) 0.022
Abbreviations: CI, confidence interval; IDRS, Indian Diabetes Risk Score; LDL, low density lipoprotein; SD, standard deviation.
 Mixed-effects linear regression was used to estimate the difference in change between study groups.
† Geometric mean (coefficient of variation) is presented for within-group change and geometric mean ratio for between-group change for skewed triglycerides.
https://doi.org/10.1371/journal.pmed.1002575.t002
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Table 3. Changes in behavioral characteristics at 24 months by study group.
Control group Intervention group Relative risk (95% CI) P value
(n/N [percent]) (n/N [percent])
5 servings of fruit and vegetables/daya
Baseline 77/507 (15.2) 68/500 (13.6) 0.90 (0.63 to 1.28) 0.56
24 months 41/482 (8.5) 67/482 (13.9) 1.83 (1.17 to 2.84) 0.008
Physically active (leisure time)b
Baseline 107/507 (21.1) 102/500 (20.4) 0.94 (0.67 to 1.33) 0.73
24 months 87/482 (18.1) 101/482 (21.0) 1.20 (0.81 to 1.79) 0.36
Current tobacco usec
Baseline 92/507 (18.2) 102/500 (20.4) 1.12 (0.81 to 1.55) 0.50
24 months 80/482 (16.6) 72/482 (14.9) 0.79 (0.60 to 1.05) 0.11
Current alcohol used
Baseline 97/507 (19.1) 114/500 (22.8) 1.19 (0.87 to 1.62) 0.29
24 months 88/482 (18.3) 81/482 (16.8) 0.77 (0.62 to 0.95) 0.018
Mean (SD) Mean (SD) Difference† (95% CI) P value
Standard drinks of alcohol (per drinking occasion)e
Baseline 0.20 (0.44) 0.23 (0.43) 0.028 (−0.032 to 0.088) 0.36
24 months 0.18 (0.39) 0.17 (0.37) −0.044 (−0.083 to −0.004) 0.030
Abbreviations: CI, confidence interval; SD, standard deviation.
 Generalized estimating equations was used to estimate the relative risk (and 95% CI).
† Mixed-effects linear regression was used to estimate the difference in mean change between study groups.
a One serving of fruit equals a medium-sized fruit or two small-sized fruits or half a glass of fruit juice or a bowl of grapes. One serving of vegetables (excludes tubers)
equals 80 grams.
b Self-reported history of moderate or vigorous physical activities during leisure time performed in bouts of at least 10 minutes’ duration.
c Smoking or use of smokeless tobacco (chewing tobacco and snuff) in the past 30 days.
d Consumed an alcoholic drink (spirits, wine, beer or toddy [palm wine]) in the past 30 days.
e One standard drink of alcohol refers to 30 ml of spirits, 120 ml of wine, 285 ml of beer, or 285 ml of toddy (palm wine).
https://doi.org/10.1371/journal.pmed.1002575.t003
Table 4. Changes in health-related quality of life variables at 24 months by study group.
Control group Intervention group
Mean change (SD) Mean change (SD) Difference (95% CI) P value
Physical functioning 1.3 (25.6) 5.0 (25.7) 3.9 (0.7 to 7.0) 0.016
Bodily pain 4.5 (33.4) 3.1 (34.3) −1.2 (−5.3 to 2.9) 0.55
Role limitation - physical 3.3 (25.4) 4.7 (26.9) 1.4 (−1.8 to 4.5) 0.40
Role limitation - emotional 3.1 (24.2) 5.9 (26.3) 2.5 (−0.6 to 5.6) 0.11
Social functioning 2.1 (25.6) 3.1 (27.0) 1.0 (−2.1 to 4.2) 0.52
Vitality 6.1 (22.1) 6.1 (21.5) 0.3 (−2.5 to 3.0) 0.85
General health 6.2 (26.5) 5.5 (27.3) −0.7 (−4.1 to 2.7) 0.68
Mental health 5.4 (22.8) 4.6 (21.5) −0.9 (−3.6 to 1.8) 0.50
Physical component summary 1.1 (9.1) 1.5 (9.0) 0.4 (−0.7 to 1.5) 0.46
Mental component summary 2.4 (10.4) 2.4 (10.0) 0.02 (−1.21 to 1.26) 0.97
SF-6D 0.04 (0.16) 0.05 (0.17) 0.01 (−0.01 to 0.03) 0.30
Abbreviations: CI, confidence interval; SD, standard deviation; SF-6D, Short Form 6 Dimension.
 Mixed-effects linear regression was used to estimate the difference in mean change between study groups.
https://doi.org/10.1371/journal.pmed.1002575.t004
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study showed that the intervention resulted in a non-significant reduction in diabetes inci-
dence at 24 months in a high-risk population identified on the basis of a diabetes risk score.
However, there were significant improvements in some cardiovascular risk factors, including
IDRS score, fruit and vegetable intake, and alcohol use, and physical functioning score of the
HRQoL scale.
Comparison with other studies
The trial was powered for a 30% RRR for diabetes incidence at 24 months and observed a
12% RRR (nonsignificant), which was lower than that reported in other effectiveness trials.
Table 5. Costs of the peer-support lifestyle intervention over 12 months.
Categories Inputs Cost (US dollars) Percent of total cost
Training sessions 1308
a. Peer leader training sessions (n = 2) 691
Personnel cost 135
Travel cost 410
Food and logistics 144
Phone calls 2
b. LRP training sessions (n = 5) 617
Personnel cost 49 11.7
Travel cost 512
Food and logistics 53
Phone calls 3
Group sessions 5928
a. Introductory group sessions (n = 30) 1636
Personnel cost 453
Travel cost 861
Rent for venues, food, and logistics 321
Phone calls 1
b. DPES (n = 14) 999
Personnel cost 198 52.8
Travel cost 402
Rent for venues, food, and logistics 397
Phone calls 2
c. Peer group sessions (n = 348) 3293
Personnel cost 2233
Rent for venues, food, and logistics 1036
Phone calls 24
Resource materialsa (n = 1560) Designing and printing charges 2441 21.7
Administrative costs 1548 13.8
Community activitiesb 0 0
Total costs 11225 100
Abbreviations: DPES, Diabetes Prevention Education Sessions; LRP, local resource person. Costs in Indian Rupees (INR) were converted to US$ using an exchange rate
of INR58.6 = US$1 for the year 2013. Personnel costs were calculated based on the time spent by the Intervention Manager (US$2.5/hr) and Intervention Assistant
(US1.1/hr) for various intervention activities, and remuneration for local experts (US$25.6/session) and LRPs (US$4.7/session).
a Includes participant handbook, peer leader handbook, peer leader workbook and health education booklet.
b Includes yoga sessions, kitchen garden training, and walking groups.
https://doi.org/10.1371/journal.pmed.1002575.t005
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A meta-analysis by Ashra and colleagues assessing the effectiveness of 13 pragmatic lifestyle
interventions implemented in routine clinical practice showed that the pooled estimate of
RRR was 26% [44]. In the Study on Lifestyle intervention and Impaired glucose tolerance
Maastricht (SLIM) study, the RRR was 58% at three years [45]. In the Joetsu Diabetes Preven-
tion Trial, the RRR varied from 27% (nonhospitalization with diabetes education and support)
to 42% (short-term hospitalization with diabetes education and support) at three years [46]. In
the Spanish Diabetes in Europe—Prevention using Lifestyle, Physical Activity and Nutritional
Intervention (DE-PLAN) project, which was implemented in primary care settings, the RRR
was 36% at four years [47]. In a mobile phone effectiveness study conducted in India, the RRR
was 36% at two years [48]. In the Diabetes Community Lifestyle Improvement (D-CLIP) trans-
lational trial conducted in India, the RRR was 32% at three years [49]. The lower effect in our
study could be attributed to the following reasons. In previous studies, most (if not all) partici-
pants had IGT, while in K-DPP, participants were identified on the basis of a risk score, and
the majority had isolated IFG or NGT, albeit with a high burden of cardiovascular risk factors
[42]. So far, from the limited recent literature available [49–51], there is no proven interven-
tion to reduce diabetes incidence among those with isolated IFG. Furthermore, 24 months’ fol-
low-up may not have been long enough to allow for an intervention effect to be observable,
and thus a longer-term follow-up has been planned.
In the control group, there was a decline in fruit and vegetable intake and the reported level
of physical activity at 24 months. These are consistent with findings from other recent longitu-
dinal studies conducted in Kerala, showing that the proportion of people meeting the recom-
mended intake of fruits and vegetables and level of physical activity is continuing to decrease
over time in the absence of any intervention [52,53]. There was a greater increase in physical
functioning score of the HRQoL scale in the intervention group at 24 months. Previous studies
have shown that improvement in HRQoL is likely to be mediated by improved physical activ-
ity and weight loss [54].
In our study, the cost of delivering the peer-support lifestyle intervention over 12 months
was US$22.5 per participant, a large percentage (52.8%) of which was accounted for by the
group sessions, the main mode of formal program delivery. This is less than one-third of the
intervention costs incurred in IDPP (US$75 per participant per year) [6]. The lower cost
could be mainly attributed to the fact that, in IDPP, health professionals (physicians, dieti-
cians, and social workers) were involved in delivering the intervention, while in K-DPP, the
intervention was delivered mainly by lay peer leaders. In IDPP, the personnel cost was US
$36 per participant, whereas in K-DPP, this cost was only US$6. However, the effect size in
IDPP (28.5%) was higher than that in K-DPP (12%). It is possible that resource-intensive
lifestyle interventions are more effective than low-resource interventions in reducing diabe-
tes progression, at least in the IGT population (S5 Table and S1 Fig). If the K-DPP interven-
tion were implemented as a real-world program, the unit costs for each individual would be
much lower. This is because the one-off costs (e.g., training of peer leaders and LRPs and
printing charges of resource materials) would be distributed over a much larger number of
individuals, and the relative travel and administrative costs would also be lower. In K-DPP,
travel and administrative costs accounted for one-third (33.3%) of the total costs. This is
because the K-DPP personnel and local experts had to travel to the field, spending around
three hours for every return trip. However, these costs would be relatively lower in a program
setting and if the program were delivered at scale. Moreover, the very important K-DPP
community activities incurred no program costs, as they were led by peer leaders with assis-
tance from LRPs.
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Strengths and limitations
The K-DPP trial has a number of strengths. The study was conducted in the Indian state of
Kerala, which has a high prevalence of diabetes (approximately 20%) and several other cardio-
vascular risk factors [52,55,56]. The state is in the most advanced stage of epidemiological tran-
sition compared to other Indian states [57], and it is also the harbinger of the future for the
rest of India in relation to the burden of chronic diseases [55,56]. Therefore, Kerala provides
an ideal setting for the implementation and evaluation of a diabetes prevention program in a
community setting in India. As far as we are aware, K-DPP is the first diabetes prevention trial
to deliver a peer-support lifestyle intervention program mainly by trained lay people in a low-
and middle-income setting. In the D-CLIP trial from Chennai, India, although peer support
was provided by community volunteers, it involved a team of health coaches and fitness train-
ers in the delivery of intervention. Also, metformin (500 mg twice a day) was added to those at
highest risk of developing diabetes [49]. Although metformin was found to be equally effective
as lifestyle intervention in previous studies [2,4] and is cheap, the current evidence base sup-
ports its use only in combination with lifestyle interventions [58]. Other strengths of our trial
include a very high follow-up rate at 24 months (97.5%), use of a rigorous study design, and a
much better representation of women (nearly half the participants were women) compared to
previous diabetes prevention trials in India [4,48,49,59]. However, there are also some study
limitations. In subgroup analyses, balance of potentially confounding characteristics between
the subgroups compared is not guaranteed, and the power may have been insufficient for such
analyses. Data on behavioral risk factors (tobacco use, alcohol use, physical activity, and fruit
and vegetable intake) were collected using questionnaires that were not validated by objective
measures and are likely to be subject to response bias. It is possible that social desirability and
acquiescence biases associated with the intervention may have resulted in the small differences
observed in some of the behavioral outcomes at 24 months. Furthermore, we did not adjust
for multiple comparison, and given the likelihood of type 1 errors [60], changes in secondary
outcomes observed should be interpreted cautiously.
Implications for policy and future research
In efficacy trials of behavioral or social interventions, recruitment of highly selected individu-
als, resource-intensive interventions, and close monitoring to ensure compliance will almost
always overestimate the outcomes that will actually be achievable under ‘real-world’ conditions
[61]. However, given that the efficacy of lifestyle interventions to prevent diabetes among
high-risk individuals, particularly among those with IGT, has been quite well established, it is
now important to determine their effectiveness in real-world settings, in which the target pop-
ulation is likely to be much broader if program participants are not recruited on the basis of
clinical testing [62]. Our study findings have some important implications for policy and
future research with regards to diabetes prevention in India (and perhaps also in other
LMICs). First, using a risk score rather than the OGTT to identify high-risk individuals was
part of our strategy to develop a low-cost diabetes prevention program. While the IDRS with a
score of60 identified individuals with a high burden of cardiovascular risk factors [42], the
majority had isolated IFG or NGT and not IGT. The results of our subgroup analyses suggest a
trend towards greater reduction in diabetes incidence among those with IGT compared to
those with isolated IFG or NGT. As mentioned previously, so far, lifestyle interventions have
not been shown to be effective in reducing diabetes risk among those with isolated IFG [49–
51]. Further research is required to determine the optimal cutoff for the IDRS to identify those
at highest risk of developing diabetes. Alternatively, risk scores that are better at picking up
people with IGT could be developed. Second, given the high burden of cardiovascular risk
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factors in the trial population [42] and improvements observed in some of these at 24 months,
it is important to evaluate the potential longer-term benefits of the intervention on both diabe-
tes incidence and cardiovascular risk. Finally, although the K-DPP intervention was low-cost
and delivered mainly by lay people in community neighborhoods with support from local self-
government bodies, it is important to do more research on how to increase program adherence
and engagement, possibly by using more flexible modes of program delivery, e.g., at worksites
and by text messaging. This research should also consider how continued program implemen-
tation beyond the current 12-month program for group participants can be supported by
developing partnerships with other kinds of community organizations or partnerships that
could deliver the intervention at scale in Kerala and elsewhere in India in the future.
Conclusions
In this low- and middle-income setting, a low-cost peer-support lifestyle intervention resulted
in a nonsignificant reduction in diabetes incidence at 24 months in a high-risk population
identified on the basis of a risk score. However, there were significant improvements in some
cardiovascular risk factors and physical functioning score of the HRQoL scale.
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